Found: 34
Select item for more details and to access through your institution.
Suramin toxicity and efficacy in agnogenic myeloid metaplasia.
- Published in:
- 1993
- By:
- Publication type:
- journal article
The genomic landscape of small intestine neuroendocrine tumors.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The genomic landscape of small intestine neuroendocrine tumors.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 6, p. 2502, doi. 10.1172/JCI67963
- By:
- Publication type:
- Article
Activity of indicine N-oxide in refractory acute leukemia.
- Published in:
- 1981
- By:
- Publication type:
- journal article
Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas.
- Published in:
- Modern Pathology, 2005, v. 18, n. 10, p. 1329, doi. 10.1038/modpathol.3800427
- By:
- Publication type:
- Article
Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Gemcitabine and Irinotecan as First-Line Therapy for Carcinoma of Unknown Primary: Results of a Multicenter Phase II Trial.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0039285
- By:
- Publication type:
- Article
Endocrine Therapy in 2009: Consideration of the Tumor and the Host.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 2, p. 150
- By:
- Publication type:
- Article
Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 5, p. 495, doi. 10.1007/s10637-005-2910-4
- By:
- Publication type:
- Article
Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen.
- Published in:
- JAMA: Journal of the American Medical Association, 2009, v. 302, n. 13, p. 1429, doi. 10.1001/jama.2009.1420
- By:
- Publication type:
- Article
Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Mouse pharmacokinetics and metabolism of the phenylurea thiocarbamate NSC 161128.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmacokinetics of dacarbazine (DTIC) in pregnancy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 575, doi. 10.1007/s00280-009-1198-z
- By:
- Publication type:
- Article
A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 1, p. 39, doi. 10.1007/s00280-007-0443-6
- By:
- Publication type:
- Article
Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 4, p. 461, doi. 10.1007/s00280-006-0285-7
- By:
- Publication type:
- Article
CYP1A1 activation of aminoflavone leads to DNA damage in human tumor cell lines.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Single-dose pharmacokinetics of the DNA-binding bioreductive agent NLCQ-1 (NSC 709257) in CD2F<sub>1</sub> mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 51, n. 6, p. 483, doi. 10.1007/s00280-003-0570-7
- By:
- Publication type:
- Article
Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 11, p. 1303, doi. 10.1002/jcph.543
- By:
- Publication type:
- Article
A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 7, p. 1246, doi. 10.1002/pbc.25023
- By:
- Publication type:
- Article
Population Pharmacokinetics of Z‐Endoxifen in Patients With Advanced Solid Tumors.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 9, p. 1121, doi. 10.1002/jcph.2053
- By:
- Publication type:
- Article
North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma.
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 18, p. 3494, doi. 10.1002/cncr.30766
- By:
- Publication type:
- Article
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 9, p. 1452, doi. 10.1002/pbc.24541
- By:
- Publication type:
- Article
Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: A Children's Oncology Group study.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 2, p. 237, doi. 10.1002/pbc.24244
- By:
- Publication type:
- Article
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916).
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 3, p. 390, doi. 10.1002/pbc.24271
- By:
- Publication type:
- Article
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: A Children's Oncology Group phase I consortium study.
- Published in:
- Pediatric Blood & Cancer, 2010, v. 54, n. 4, p. 538, doi. 10.1002/pbc.22407
- By:
- Publication type:
- Article
A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: A Children's Oncology Group study.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 50, n. 4, p. 788, doi. 10.1002/pbc.21310
- By:
- Publication type:
- Article
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM.
- Published in:
- Journal of Neuro-Oncology, 2010, v. 99, n. 1, p. 73, doi. 10.1007/s11060-009-0103-2
- By:
- Publication type:
- Article
Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00606-2
- By:
- Publication type:
- Article
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance).
- Published in:
- Oncologist, 2019, v. 24, n. 5, p. 589, doi. 10.1634/theoncologist.2018-0878
- By:
- Publication type:
- Article
Characterization of Batracylin-induced Renal and Bladder Toxicity in Rats.
- Published in:
- Toxicologic Pathology, 2015, v. 43, n. 4, p. 519, doi. 10.1177/0192623314548766
- By:
- Publication type:
- Article
Comparative Uterotrophic Effects of Endoxifen and Tamoxifen in Ovariectomized Sprague-Dawley Rats.
- Published in:
- Toxicologic Pathology, 2014, v. 42, n. 8, p. 1188, doi. 10.1177/0192623314525688
- By:
- Publication type:
- Article
Synthesis of N-hydroxymethylpentamethylmelamine (ring <sup>14</sup>C), a cytotoxic-alkylating metabolite of hexamethylmelamine.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 1984, v. 21, n. 10, p. 893, doi. 10.1002/jlcr.2580211002
- By:
- Publication type:
- Article
Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.
- Published in:
- 2015
- By:
- Publication type:
- journal article